Sign In
Buy HSY
$182.71
-0.490 (-0.267%)
At Close: Jun 04, 2026
Hershey's Q3 results ‘cleared a high bar' but outlook conservative, says UBS analyst
12:11pm, Friday, 04'th Nov 2022
Hershey Co.'s third-quarter results surpassed investors' lofty expectations but the company's raised outlook is conservative, according to UBS analyst Cody Ross.
Daily Dividend Report: Snap-On, Capital One Financial, Hershey, UnitedHealth Group, Dominion Energy
11:39am, Friday, 04'th Nov 2022
Daily Dividend Report: Snap-On, Capital One Financial, Hershey, UnitedHealth Group, Dominion Energy
The Hershey Company (HSY) Q3 2022 Earnings Call Transcript
11:33am, Friday, 04'th Nov 2022
The Hershey Company (NYSE:HSY ) Q3 2022 Earnings Conference Call November 4, 2022 8:30 AM ET Company Participants Melissa A. Poole – Vice President-Investor Relations Michele Buck – Chairman and C
Fear & Greed Index Moves To 'Neutral' Zone Ahead Of US NFP Report
11:26am, Friday, 04'th Nov 2022 Benzinga
The CNN Money Fear and Greed index moved to the "Neutral" zone a day after the Federal Reserve announced another 0.75 percentage point rate hike on Wednesday.
U.S. stocks recorded losses for the fourt
Hershey (HSY) Q3 Earnings and Revenues Beat Estimates
09:48am, Friday, 04'th Nov 2022
Hershey (HSY) delivered earnings and revenue surprises of 4.83% and 4.19%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Hershey, PayPal And 3 Stocks To Watch Heading Into Friday
09:02am, Friday, 04'th Nov 2022 Benzinga
With US stock futures trading higher this morning on Friday, some of the stocks that may grab investor focus today are as follows:
Wall Street expects Cardinal Health, Inc. (NYSE: CAH) to report qu
Hershey stock climbs on Q3 revenue beat, raised outlook
07:31am, Friday, 04'th Nov 2022
Hershey Co.'s HSY, -1.28% stock rose 2.4% before market open Friday after the company reported better-than-expected third-quarter revenue and raised its outlook. The maker of Reese's Peanut Butter Cup
Why Hershey (HSY) Might Surprise This Earnings Season
11:20am, Thursday, 03'rd Nov 2022
Hershey (HSY) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for International Flavors' (IFF) Q3 Earnings?
03:35pm, Wednesday, 02'nd Nov 2022 Zacks Investment Research
International Flavors' (IFF) Q3 performance is likely to reflect benefits from robust demand for home care and personal categories, although escalating costs might have been a spoilsport.
Hershey (HSY) Q3 Earnings Upcoming: Here's All You Should Note
04:34pm, Tuesday, 01'st Nov 2022 Zacks Investment Research
Hershey's (HSY) third-quarter 2022 performance will likely reflect gains from prudent acquisitions and strategic pricing efforts. However, rising cost inflation is likely to have been a concern.
Stocks Trading Near All-Time Highs Warrant Caution
02:33pm, Tuesday, 01'st Nov 2022
Despite the precipitous decline in FAANG and tech stocks this year, blue-chip stocks are having incredible runs. Some are calling it the revenge of the Dow.
Hershey (HSY) Q3 Earnings Upcoming: Here's All You Should Note
02:19pm, Tuesday, 01'st Nov 2022
Hershey's (HSY) third-quarter 2022 performance will likely reflect gains from prudent acquisitions and strategic pricing efforts. However, rising cost inflation is likely to have been a concern.
Medifast's (MED) Q3 Earnings Upcoming: Things Worth Noting
11:47am, Tuesday, 01'st Nov 2022 Zacks Investment Research
Medifast's (MED) third-quarter 2022 results are likely to reflect cost-related challenges, whereas strength in the OPTAVIA lifestyle solution and coaching support system bodes well.
What Awaits The Estee Lauder Companies (EL) in Q1 Earnings?
04:58pm, Monday, 31'st Oct 2022 Zacks Investment Research
The Estee Lauder Companies (EL) Q1 performance will likely reflect adverse impacts from record inflation and supply chain disruptions. That said, strength in online sales is a breather.
Nu Skin (NUS) Queued for Q3 Earnings: Things to Consider
04:53pm, Monday, 31'st Oct 2022 Zacks Investment Research
Nu Skin's (NUS) Q3 performance will likely reflect continued economic uncertainty, prolonged COVID-associated factors, unfavorable currency rates and geopolitical conflicts.
